CoChat

Managing thyroid disease in general practice

Walsh, John P · 2016 · Medical Journal of Australia
Cited by 92

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Serum thyroid-stimulating hormone (TSH) testing is the best screening tool for thyroid dysfunction. When TSH levels are in the reference range, additional tests such as free thyroxine, free triiodothyronine or thyroid antibodies rarely add value, except in patients with pituitary disease, when TSH is unreliable. Overt hypothyroidism and subclinical hypothyroidism with TSH levels > 10 mU/L can be treated without further investigation. The health impact of subclinical hypothyroidism with mildly elevated levels of TSH (4-10 mU/L) remains uncertain, particularly in older people; treatment or observation are reasonable options. Thyroxine remains standard treatment for hypothyroidism, with optimal dosage determined by clinical response and serum TSH. Hyperthyroidism is commonly caused by Graves' disease, thyroiditis or toxic nodular goitre. The cause should be established before offering treatment. Radionuclide scanning is the imaging modality of choice. Positive TSH-receptor antibodies indicate Graves' disease. Thyroid ultrasound is indicated for assessment of palpable goitre and thyroid nodules. It is not part of routine assessment of hyperthyroidism or hypothyroidism. Overzealous use of ultrasound identifies clinically unimportant thyroid nodules and can lead to overdiagnosis of thyroid cancer. For thyroid nodules, the key investigation is ultrasound-guided fine needle aspiration biopsy, depending on size and sonographic appearance. Biopsy should not be performed routinely on small nodules < 1 cm. It remains controversial whether pregnant women should be screened for thyroid disease. Reference intervals for thyroid function tests during pregnancy are not well established, and it is uncertain whether thyroxine treatment for pregnant women with serum TSH levels between 2.5 and 4.0 mU/L is beneficial. Iodine supplementation is recommended during pregnancy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5694/mja16.00545

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 28

  1. 10.5694/j.1326-5377.2006.tb00177.x · DOI · Paper page
  2. 2011, Feature Article: Iodine
  3. 10.1111/j.1365-2265.2005.02424.x · DOI · Paper page
  4. 10.1210/jc.2011-1724 · DOI · Paper page
  5. 2015, Endocrine Society of Australia
  6. 10.1001/jama.2010.1361 · DOI · Paper page
  7. 10.1016/S1471-4892(02)00209-6 · DOI
  8. Zuuren EJ, 2013, Selenium supplementation for Hashimoto's thyroiditis, Cochrane Database Syst Rev, 6, CD010223
  9. 10.1210/er.2002-0016 · DOI · Paper page
  10. 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3 · DOI · Paper page
  11. 10.1001/jamaoto.2014.1 · DOI · Paper page
  12. 10.1111/cen.12724 · DOI
  13. 10.1089/105072502753522374 · DOI
  14. 10.1136/bmj.f4706 · DOI · Paper page
  15. 10.1056/NEJMp1409841 · DOI · Paper page
  16. 10.1111/cen.12232 · DOI
  17. 10.1210/jc.2012-4249 · DOI · Paper page
  18. 10.5694/j.1326-5377.2007.tb01057.x · DOI
  19. 10.1210/jc.2011-2803 · DOI · Paper page
  20. 10.1136/bmj.g4929 · DOI · Paper page
  21. 10.1136/bmj.h4726 · DOI
  22. 10.1373/clinchem.2014.236646 · DOI · Paper page
  23. LaurbergP AndersenSL HinderssonP et al.Dynamics and predictors of serum TSH and fT4 reference limits in early pregnancy. A study within the Danish National Birth Cohort.J Clin Endocrinol Metab2016:101: 2484–2492. · DOI
  24. 10.1089/thy.2015.0418 · DOI · Paper page
  25. 10.1210/jc.2014-1918 · DOI
  26. 10.1210/jc.2008-1520 · DOI · Paper page
  27. 10.1210/jc.2005-1603 · DOI · Paper page
  28. 10.1530/EJE-14-1005 · DOI

Cited by

Metadata

Authors
Walsh, J. P.
Venue
Medical Journal of Australia
Publisher
AMPCo
Published
2016-08
Volume
205
Issue
4
Pages
179-184
ISSN
  • 0025-729X (ISSN-L)
  • 1326-5377
OpenAlex
W2501650478
Cited by
92
References
22
FWCI
5.20
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.